Cite

HARVARD Citation

    Tepper, S. et al. (2020). Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks. Headache. 60 (8), pp. 1601-1615. [Online]. 
  
Back to record